Company intelligence / Profile preview

ChitoLytic

St. John's, Newfoundland and Labrador, Canadachitolytic.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

ChitoLytic is a North American biotech company specializing in the manufacture and supply of high-quality chitosan for R&D and commercial use. Their products are used in biomedical, pharmaceutical, medical device, nutraceutical, cosmetic, food/agriculture industries. They do not develop proprietary drugs or therapies but enable research and product development through their materials.

Therapeutic areas: OtherDermatology
Modalities: BiologicRecombinant protein (chitosan and derivatives)Nanoparticle (for drug delivery applications)
Industry: Non-Drug Biotech

Partnerships

Academic partnership with Flinders University/Centre for Marine Bioproducts Development to scale up all-natural sunscreen technology using chitosan

Beyond the preview

Go deeper on ChitoLytic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChitoLytic.

Explore the full profile